Glucocorticoid use in psoriatic arthritis and treatment outcomes: does the gender have a role?

[1] Madland TM(2005)Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway J Rheumatol 32 1918-1922

[2] Apalset EM(2019)Trends in the prevalence and ıncidence of psoriasis and psoriatic arthritis in Ontario, Canada: a population-based study Arthritis Care Res 71 1084-1091

[3] Johannessen AE(2005)Epidemiology of psoriatic arthritis in the population of the United States J Am Acad Dermatol 53 573-740

[4] Rossebö B(2013)High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires Ann Rheum Dis 72 736-1170

[5] Brun JG(2007)Consensus on a core set of domains for psoriatic arthritis J Rheumatol 34 1167-1394

[6] Eder L(2009)Treatment recommendations for psoriatic arthritis Ann Rheum Dis 68 1387-712

[7] Widdifield J(2020)EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update Ann Rheum Dis 79 700-479

[8] Rosen CF(2022)GRAPPA Treatment Recommendations domain subcommittees. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021 Nat Rev Rheumatol 18 465-208

[9] Cook R(2016)Sex differences in the treatment of psoriatic arthritis: a systematic literature review Isr Med Assoc J 18 203-582

[10] Lee KA(2013)Gender difference in disease expression, radiographic damage and disability among patients with psoriatic arthritis Ann Rheum Dis 72 578-1660

[1] Madland TM(2005)Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway J Rheumatol 32 1918-1922

[2] Apalset EM(2019)Trends in the prevalence and ıncidence of psoriasis and psoriatic arthritis in Ontario, Canada: a population-based study Arthritis Care Res 71 1084-1091

[3] Johannessen AE(2005)Epidemiology of psoriatic arthritis in the population of the United States J Am Acad Dermatol 53 573-740

[4] Rossebö B(2013)High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires Ann Rheum Dis 72 736-1170

[5] Brun JG(2007)Consensus on a core set of domains for psoriatic arthritis J Rheumatol 34 1167-1394

[6] Eder L(2009)Treatment recommendations for psoriatic arthritis Ann Rheum Dis 68 1387-712

[7] Widdifield J(2020)EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update Ann Rheum Dis 79 700-479

[8] Rosen CF(2022)GRAPPA Treatment Recommendations domain subcommittees. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021 Nat Rev Rheumatol 18 465-208

[9] Cook R(2016)Sex differences in the treatment of psoriatic arthritis: a systematic literature review Isr Med Assoc J 18 203-582

[10] Lee KA(2013)Gender difference in disease expression, radiographic damage and disability among patients with psoriatic arthritis Ann Rheum Dis 72 578-1660